Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model

Renin angiotensin system (RAS) blockade reduces the progression of chronic kidney disease (CKD) independently of its antihypertensive effect. Ang II-induced fibrosis can be mediated by molecules such as klotho, peroxisome proliferator-activate receptor γ (PPAR-γ), and the Wnt/β-catenin pathway; howe...

Full description

Bibliographic Details
Main Authors: Edgar Maquigussa, Josne C. Paterno, Gabriel H. de Oliveira Pokorny, Mariana da Silva Perez, Vanessa A. Varela, Antônio da Silva Novaes, Nestor Schor, Mirian A. Boim
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2018.01033/full
id doaj-68f9f77649974c2d8ae9ab856253f374
record_format Article
spelling doaj-68f9f77649974c2d8ae9ab856253f3742020-11-24T22:07:25ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2018-08-01910.3389/fphys.2018.01033369475Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy ModelEdgar MaquigussaJosne C. PaternoGabriel H. de Oliveira PokornyMariana da Silva PerezVanessa A. VarelaAntônio da Silva NovaesNestor SchorMirian A. BoimRenin angiotensin system (RAS) blockade reduces the progression of chronic kidney disease (CKD) independently of its antihypertensive effect. Ang II-induced fibrosis can be mediated by molecules such as klotho, peroxisome proliferator-activate receptor γ (PPAR-γ), and the Wnt/β-catenin pathway; however, the interaction among these molecules and RAS activation is not completely known. The aim of this study was to investigate a possible link between RAS, PPAR-γ, and Klotho in the 5/6 nephrectomy (NX) animals. NX rats presented hypertension that was blunted by both losartan and propranolol, however, only losartan was able to reduce the expression levels of fibronectin FSP1 and TGF-β in the remnant kidney. The anti-fibrotic Klotho and PPAR-γ were reduced in the remnant kidney, and losartan, but not propranolol, restored their levels. In contrast, the profibrotic Wnt 7a and Wnt 3 were upregulated and losartan prevented the increase in Wnts. In vitro, Ang II induced a decrease in both klotho and in PPAR-γ in Madin-Darby canine kidney (MDCK) cells, and this effect was blunted by losartan. However, klotho expression was increased by pioglitazone, an agonist of PPAR-γ, and suppressed by BADGE, an antagonist of PPAR-γ, suggesting that the effect of Ang II downregulating klotho is mediated by PPAR-γ. These data suggest that activation of the Wnt pathway together with downregulation of PPAR-γ that in turn suppresses klotho contribute to potentiating the profibrotic effect of Ang II.https://www.frontiersin.org/article/10.3389/fphys.2018.01033/fullklothoangiotensin IIPPAR-γchronic kidney diseasehypertension
collection DOAJ
language English
format Article
sources DOAJ
author Edgar Maquigussa
Josne C. Paterno
Gabriel H. de Oliveira Pokorny
Mariana da Silva Perez
Vanessa A. Varela
Antônio da Silva Novaes
Nestor Schor
Mirian A. Boim
spellingShingle Edgar Maquigussa
Josne C. Paterno
Gabriel H. de Oliveira Pokorny
Mariana da Silva Perez
Vanessa A. Varela
Antônio da Silva Novaes
Nestor Schor
Mirian A. Boim
Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model
Frontiers in Physiology
klotho
angiotensin II
PPAR-γ
chronic kidney disease
hypertension
author_facet Edgar Maquigussa
Josne C. Paterno
Gabriel H. de Oliveira Pokorny
Mariana da Silva Perez
Vanessa A. Varela
Antônio da Silva Novaes
Nestor Schor
Mirian A. Boim
author_sort Edgar Maquigussa
title Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model
title_short Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model
title_full Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model
title_fullStr Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model
title_full_unstemmed Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model
title_sort klotho and ppar gamma activation mediate the renoprotective effect of losartan in the 5/6 nephrectomy model
publisher Frontiers Media S.A.
series Frontiers in Physiology
issn 1664-042X
publishDate 2018-08-01
description Renin angiotensin system (RAS) blockade reduces the progression of chronic kidney disease (CKD) independently of its antihypertensive effect. Ang II-induced fibrosis can be mediated by molecules such as klotho, peroxisome proliferator-activate receptor γ (PPAR-γ), and the Wnt/β-catenin pathway; however, the interaction among these molecules and RAS activation is not completely known. The aim of this study was to investigate a possible link between RAS, PPAR-γ, and Klotho in the 5/6 nephrectomy (NX) animals. NX rats presented hypertension that was blunted by both losartan and propranolol, however, only losartan was able to reduce the expression levels of fibronectin FSP1 and TGF-β in the remnant kidney. The anti-fibrotic Klotho and PPAR-γ were reduced in the remnant kidney, and losartan, but not propranolol, restored their levels. In contrast, the profibrotic Wnt 7a and Wnt 3 were upregulated and losartan prevented the increase in Wnts. In vitro, Ang II induced a decrease in both klotho and in PPAR-γ in Madin-Darby canine kidney (MDCK) cells, and this effect was blunted by losartan. However, klotho expression was increased by pioglitazone, an agonist of PPAR-γ, and suppressed by BADGE, an antagonist of PPAR-γ, suggesting that the effect of Ang II downregulating klotho is mediated by PPAR-γ. These data suggest that activation of the Wnt pathway together with downregulation of PPAR-γ that in turn suppresses klotho contribute to potentiating the profibrotic effect of Ang II.
topic klotho
angiotensin II
PPAR-γ
chronic kidney disease
hypertension
url https://www.frontiersin.org/article/10.3389/fphys.2018.01033/full
work_keys_str_mv AT edgarmaquigussa klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel
AT josnecpaterno klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel
AT gabrielhdeoliveirapokorny klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel
AT marianadasilvaperez klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel
AT vanessaavarela klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel
AT antoniodasilvanovaes klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel
AT nestorschor klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel
AT mirianaboim klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel
_version_ 1725820551773028352